Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL6 | P41182 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 3/20 | 0.36 |
| ▸ | CDK2 | P24941 | 3/20 | 0.36 |
| ▸ | GSK3B | P49841 | 3/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.36 |
| ▸ | CDC7 | O00311 | 2/20 | 0.36 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.36 |
| ▸ | FLT3 | P36888 | 2/20 | 0.36 |
| ▸ | CDK9 | P50750 | 2/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.36 |
| ▸ | MELK | Q14680 | 2/20 | 0.36 |
| ▸ | HIPK2 | Q9H2X6 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9325233 | 0.91 | BCL6 (0.49) | BCL6MEN1KMT2AMAPTKDM4E | |
| SCHEMBL16628624 | 0.79 | CYP1A2 (0.38) | BCL6MEN1KMT2AMAPTKDM4E | |
| SCHEMBL16628623 | 0.78 | TDP1 (0.42) | MEN1KMT2AMAPTKDM4EGAA | |
| SCHEMBL10382991 | 0.78 | HTT (0.43) | BCL6MEN1KMT2AMAPTPIM1 | |
| SCHEMBL609197 | 0.76 | BCL6 (0.57) | BCL6MEN1KMT2AMAPTKDM4E | |
| SCHEMBL29134257 | 0.73 | ALDH1A1 (0.56) | BCL6MEN1KMT2AMAPTKDM4E | |
| SCHEMBL444976 | 0.67 | MAPT (0.70) | MEN1KMT2AMAPTKDM4EGAA | |
| SCHEMBL29477063 | 0.67 | FABP3 (0.46) | MEN1KMT2AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL28640878 | 0.67 | MAPT (0.45) | BCL6MEN1KMT2AMAPTKDM4E | |
| SCHEMBL4774160 | 0.66 | BCL6 (0.46) | BCL6MEN1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3505522-B1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | MORI KUNIO (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-10385076-B2 | Surface treatment agent and novel compound | Mori, Kunio (JP) | 2019-08-20 | — | — | US | disclosed |
| EP-3505522-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | Mori, Kunio (JP) | 2019-07-03 | — | — | EP | disclosed |
| EP-2859962-B1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | MORI KUNIO (JP) | 2019-01-23 | — | — | EP | disclosed |
| US-20170334933-A1 | SURFACE TREATMENT AGENT AND NOVEL COMPOUND | Mori, Kunio (JP) | 2017-11-23 | — | — | US | disclosed |
| US-9790242-B2 | Surface treatment method, surface treatment agent, and novel compound | Mori, Kunio (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20150152124-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | Mori, Kunio (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2859962-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | Mori, Kunio (JP) | 2015-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152124-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | EPCAM, ITGAM, MET | BCL6 1975/4885MEN1 1048/4885KMT2A 330/4885 |
| US-20170334933-A1 | SURFACE TREATMENT AGENT AND NOVEL COMPOUND | EPCAM, MET, ITGAM | BCL6 2590/4885MEN1 857/4885KMT2A 502/4885 |
| US-10385076-B2 | Surface treatment agent and novel compound | EPCAM, MET, ITGAM | BCL6 2590/4885MEN1 857/4885KMT2A 502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.